Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bioceres Crop Solutions (BIOX) Equity Average (2017 - 2025)

Historic Equity Average for Bioceres Crop Solutions (BIOX) over the last 8 years, with Q3 2025 value amounting to $291.8 million.

  • Bioceres Crop Solutions' Equity Average fell 1632.6% to $291.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $291.8 million, marking a year-over-year decrease of 1632.6%. This contributed to the annual value of $323.3 million for FY2025, which is 517.36% down from last year.
  • Per Bioceres Crop Solutions' latest filing, its Equity Average stood at $291.8 million for Q3 2025, which was down 1632.6% from $320.1 million recorded in Q2 2025.
  • In the past 5 years, Bioceres Crop Solutions' Equity Average registered a high of $350.0 million during Q2 2024, and its lowest value of $78.1 million during Q1 2021.
  • For the 5-year period, Bioceres Crop Solutions' Equity Average averaged around $268.3 million, with its median value being $320.1 million (2025).
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 24881.7% in 2021, then tumbled by 1632.6% in 2025.
  • Quarter analysis of 5 years shows Bioceres Crop Solutions' Equity Average stood at $242.4 million in 2021, then rose by 28.16% to $310.7 million in 2022, then increased by 7.48% to $333.9 million in 2023, then rose by 3.66% to $346.2 million in 2024, then fell by 15.72% to $291.8 million in 2025.
  • Its Equity Average was $291.8 million in Q3 2025, compared to $320.1 million in Q2 2025 and $345.7 million in Q1 2025.